📅 2026 Update: Advances in Mesothelioma Treatment and Legal Support

Since the original article was published, there have been significant changes in the treatment landscape for mesothelioma. New therapies have received FDA approval, and updated guidelines are reshaping how this disease is managed. The earlier article continues further down the page and covers related topics such as asbestos exposure and legal claims.

🩺 FDA Approvals for Mesothelioma Treatments

In September 2024, the FDA approved Keytruda® (pembrolizumab) for treating unresectable advanced or metastatic pleural mesothelioma. This approval was based on the KEYNOTE-483 trial, which showed a median overall survival of 17.3 months for those receiving the drug with chemotherapy, compared to 16.1 months for chemotherapy alone.

  • 🥇 Opdivo® (Nivolumab) and Yervoy® (Ipilimumab): In 2024, the FDA also approved the combination of these two drugs as a first-line treatment for inoperable malignant pleural mesothelioma. The CheckMate 743 trial showed a median overall survival of 18.1 months, significantly better than 14.1 months for chemotherapy alone.

🏥 Changes in Surgical Recommendations

The NCCN 2026 guidelines now recommend pleurectomy/decortication (P/D) over extrapleural pneumonectomy (EPP) for pleural mesothelioma. EPP is now reserved for rare cases, and surgery is no longer listed as an option for stage 2 through stage 4 pleural mesothelioma, reflecting a more conservative approach.

💰 Current Treatment Costs

As of October 2026, the average wholesale price for Keytruda® is approximately $10,000 per 100 mg vial. The costs for the Opdivo® and Yervoy® combination are $7,000 for Opdivo® and $1,200 for Yervoy® per respective vial. The total treatment cost will vary based on dosage and insurance coverage.

🧪 Ongoing Clinical Trials

Clinical trial enrollment deadlines for new mesothelioma treatments vary. Patients interested in participating should consult their healthcare providers for specific details. This is crucial for accessing cutting-edge therapies that could improve outcomes.

📌 Key Points Summary

  • 🩺 Keytruda® and Opdivo®/Yervoy® now approved for mesothelioma.
  • 🏥 NCCN guidelines recommend P/D over EPP.
  • 💰 Treatment costs vary significantly based on drugs and insurance.
  • 🧪 Clinical trials remain an important option for new treatments.

💡 Tips for Navigating Mesothelioma Treatment Options

Consider discussing your specific situation carefully with your attorney.

🩺 Understand Treatment Options

Be aware of the recent FDA approvals for Keytruda® and the Opdivo® and Yervoy® combination. These therapies have shown promise in extending survival for patients with advanced mesothelioma.

📅 Check Clinical Trials

Investigate ongoing clinical trials that may offer access to new treatments. Discuss potential participation with your healthcare provider to stay informed about the latest options available.

💬 Ask About Multimodal Therapy

Multimodal therapy combines different treatment methods. Recent studies suggest that adding surgery may not improve survival rates. Discuss the best approach based on your health condition.

🏥 Follow Updated Guidelines

Stay up-to-date with the latest NCCN guidelines for mesothelioma treatment. These guidelines reflect the most current practices for managing this disease.

📞 Utilize Support Resources

Reach out to organizations like the Mesothelioma Applied Research Foundation and the National Cancer Institute. They provide valuable support, information, and resources for patients and families affected by mesothelioma.

🏆 Free Options Ranked by User Reviews (2026)

No national paid service in this area met the review threshold. Instead, this section lists free government and nonprofit resources that can help individuals affected by mesothelioma.

🥇 1. Mesothelioma Applied Research Foundation

This nonprofit organization offers resources and support for mesothelioma patients and their families. They provide information on treatment options, clinical trials, and financial assistance for those affected by this disease.

🥈 2. National Cancer Institute (NCI)

The NCI provides comprehensive information on mesothelioma, including treatment options and clinical trials. They offer resources that help patients understand their diagnosis and navigate the healthcare system.

🥉 3. Clinical Trials.gov

This government resource lists ongoing clinical trials for mesothelioma treatments. Patients can search for trials based on their specific conditions and learn about eligibility requirements.

4️⃣ Centers for Disease Control and Prevention (CDC)

The CDC provides information on asbestos exposure and health effects. They also offer resources for individuals looking to learn more about prevention and treatment options related to mesothelioma.

🔎 Important Points to Consider Before Paying for Help

  • 📄 Check for credentials: Ensure any resource you consider has valid credentials and is trustworthy.
  • ⏳ Verify timelines: Understand the timing of services or treatments and what to expect.
  • 💬 Read testimonials: Look for reviews from other patients or families to gauge effectiveness.
  • 🔍 Ask about costs: Be clear on any potential costs involved before proceeding with services.

❓ Frequently Asked Questions

❔ What is mesothelioma?

Mesothelioma is a type of cancer that affects the lining of the lungs, abdomen, or heart. It is primarily caused by exposure to asbestos.

🌟 How can I find clinical trials for mesothelioma?

You can find clinical trials through resources like Clinical Trials.gov or by discussing with your healthcare provider. They can help you understand eligibility and the benefits of participating.

🏥 What treatments are currently available for mesothelioma?

Current treatments include chemotherapy, immunotherapy, and surgery. New FDA-approved drugs like Keytruda® and the Opdivo® and Yervoy® combination are now available options.

🕒 How long does the FDA approval process take for new treatments?

The FDA approval process can take several years, involving extensive clinical trials and data analysis. Recent approvals took years of research before being granted in 2024.

📋 What are the NCCN guidelines for mesothelioma treatment?

The NCCN guidelines provide recommendations on how to treat mesothelioma based on the latest research. The 2026 guidelines favor pleurectomy/decortication over extrapleural pneumonectomy for most cases.

📞 Where can I find support for mesothelioma patients?

Organizations like the Mesothelioma Applied Research Foundation and the National Cancer Institute offer support, resources, and information for patients and families affected by mesothelioma.

⚖️ Recent Court Rulings on Mesothelioma Cases

Recent court rulings have clarified various aspects of mesothelioma claims, impacting how patients and families pursue justice for asbestos exposure.

For more recent rulings, feel free to browse more rulings on the news page.

End of October 2026 Update






 



What is Photodynamic Therapy? 



 

Photodynamic Therapy


 



Photodynamic therapy is applied to treat a number of medical conditions, including malignant cancers such as mesothelioma. Photodynamic therapy is a revered treatment option for its minimally toxic and minimally invasive methods. 



 



 



Although the potential and applicability of photodynamic therapy has been known for centuries, the development of modern applications has been gradual, involving a number of advancements in the fields of cancer biology and photobiology, as well as the development of modern photonic instruments, such as LEDs and lasers. 



 



 



The bulk of modern Photodynamic therapy applications utilize three core components: a light source, tissue oxygen and a photosensitizer. The combination of these components yields a chemical destruction of any tissues which are either selected by the photosensitizer or have been locally exposed to the light. To achieve the selective destruction of the targeted cells or tissue using Photodynamic therapy while leaving surrounding/healthy tissues unharmed, either the photosensitive targets must be locally excited with the attached light or the photosensitizer must be applied locally to the target area.  



 



 



Advantages and Limitations of Photodynamic Therapy:



 



 



Photodynamic therapy is regarded as both minimally toxic and minimally invasive. These advantages make Photodynamic therapy an attractive alternative to more intrusive cancer or mesothelioma treatment methods. When compared to radio surgical operations, chemotherapy and radiotherapy, for the treatment of cancerous diseases, Photodynamic therapy is also significantly cheaper. Moreover, post-operative recovery for Photodynamic therapy patients is typically just a few hours. 



 



 



Dissimilar to chemotherapy treatment options for cancer, the effect of Photodynamic therapy is localized. This specificity of treatment is achieved in the following ways:



 



 



•Light is first delivered solely to the tissues that a medical professional wishes to treat. With the absence of light, activation of the photosensitizer is not possible. When this occurs, cancerous cells cannot be targeted nor killed. 



 



 



•Secondly, photosensitizers can be administered in ways that impede or limit cancerous cells mobility. 



 



 



•And lastly, photosensitizers may be employed to selectively absorb—at a rapid rate—cancerous cells. 



 



 



To successfully utilize Photodynamic therapy, light must be present to activate the photosensitizers. This factor is crucial and previously limited the development of Photodynamic therapy—traditional wavelengths of light had difficulty penetrating tissue. 



 



 



Photodynamic Therapy as a Mesothelioma Treatment Option:



 



 



Photodynamic therapy uses laser lights to terminate cancerous cells. The Food and Drug Administration currently approves the use of these lasers to combat non-small cell lung cancers and cancer of the esophagus. That being said, Photodynamic therapy is currently in the experimental stages as a possible mesothelioma treatment option.



 



 



Although Photodynamic therapy is currently not used in the United States to combat mesothelioma cancer, the groundbreaking technology is employed overseas to treat mesothelioma patients. Abroad, Photodynamic therapy involves doctors injecting mesothelioma patients with Photofrin, a drug that targets and bonds to mesothelioma cancer cells. This special drug lies dormant until Photodynamic therapy lasers or LEDs are shined on it. When light interacts with this drug it becomes active and terminates tumor/cancer cells. To activate the drug, Medical professionals will insert a fiber optic cable into the patient’s chest cavity. The cable is attached with a high-resolution light that triggers the drug’s location. When the light hits the drug, it immediately activates and goes to work. 



 



 



When the light interacts with the drug it creates a special oxygen bond that eats away at the cancerous cells. Aim and timing are crucial in Photodynamic therapy; the medical professional performing the procedure must position the light only on the cancerous cells that are bound with the drug. Problem is, the drug also may bond with healthy cells, complicating the doctor’s job in pinpointing the cancerous cells. 



 



 



The primary drawback to Photodynamic therapy for mesothelioma patients is that the laser light is not particularly strong; typically the light can only penetrate three centimeters. Because of this limited strength, Photodynamic therapy is most effective against tumors that are close to the skin or on the surface of internal organs. Photodynamic therapy also only utilizes mesothelioma drugs that are susceptible to being absorbed by healthy cells, as well as cancerous ones. 



 



 



As stated above, Photodynamic therapy for more generic cancers yield routine or limited side effects. However, in terms of fighting mesothelioma, Photodynamic therapy presents slightly more significant side effects, including an increase in the body’s sensitivity to light and severe nausea.